2012 Italy Tumor Marker Testing Market Outlook: Growth Opportunities and StrategiesVenture Planning GroupApril 24, 2012 570 Pages - SKU: VPG3869446 |
More Oncology/Hematology reports by Venture Planning Group
Hematology and Flow Cytometry in Europe: Market Segment Forecasts and Supplier Shares by Venture Planning Group
This unique report provides information not available from any other published source, including test volume forecasts, instrument placements and installed base by manufacturer and model, ...
Spanish Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers by Venture Planning Group
This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including:Major issues pertaining to the Spanish laboratory practice, as well as key economic, ...
2013 Analysis of the PT and APTT Point-of-Care Testing Market: US, Germany, Spain,-Physician Offices, Emergency Rooms, Operating Suites, ICIs/CUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers by Venture Planning Group
This new 366-page report from Venture Planning Group, 2013 Analysis of the PT and APTT Point-of-Care Testing Market: US, Germany, Spain,-Physician Offices, Emergency Rooms, Operating ...
Competing in the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK by Venture Planning Group
See all reports like this >>This new 820-page five-country report from Venture Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five ...
More Italy Oncology/Hematology reports
PharmaPoint: Chronic Myeloid Leukemia (CML) - Italy Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Chronic Myeloid Leukemia (CML) - Italy Drug Forecast and Market Analysis to 2022SummaryGlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia (CML) ...
Competing in the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK by Venture Planning Group
This new 820-page five-country report from Venture Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five ...
PharmaPoint: Prostate Cancer - Italy Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Prostate Cancer - Italy Drug Forecast and Market Analysis to 2022SummaryGlobalData has released its new Country report, “PharmaPoint: Prostate Cancer - Italy Drug Forecast ...
2013 Italian Hospital Cancer Diagnostics Market by Venture Planning Group
See all reports like this >>This new report from Venture Planning Group contains 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital cancer diagnostics market, including:
...
More Italy reports
D&B Country RiskLine Report: Italy by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: Italy by Dun & Bradstreet Inc.
See all reports like this >>D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Oncology/Hematology Reports
